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Polychlorinated biphenyls (PCBs), poly-
chlorinated dibenzo-p-dioxins (PCDDs), and
polychlorinated dibenzofurans (PCDFs) are
extremely persistent environmental com-
pounds that adversely affect the health of
humans and other animals. These com-
pounds are toxic to the fetal and early post-
natal developing brain, which is exposed via
the placenta and breast milk as a result of
maternal exposure (Gladen and Rogan 1991;
Safe 1994; Tilson et al. 1990; Tilson and
Kodavanti 1997), even if the exposure level is
too low to induce maternal toxicity (Chen
et al. 1992; Jacobson and Jacobson 1996a;
Jacobson et al. 1985, 1990). Jacobson and
Jacobson (1996b) suggested that exposure to
PCBs in utero induced intellectual impairment
in children born to mothers who consumed
excessive amounts of sport ﬁsh obtained from
the Great Lakes area in the United States.
Disruption of cognitive development among
children exposed to dioxins and PCBs has
been documented in accidental human expo-
sures, such as in the Yusho and Yu-cheng inci-
dences (Aoki 2001), and confirmed in
experimental animals (Giesy and Kannan
1998; Jacobson and Jacobson 1997). In addi-
tion, exposure to PCBs may alter dendrito-
genesis in several brain regions during
development (Kimura-Kuroda et al. 2005;
Lein et al. 2007).
The effects of PCBs/dioxins on the brain
have been interpreted in several ways. First,
dioxin-like PCB congeners are able to bind to
and activate aryl hydrocarbon receptors
(AhRs), exerting various toxic effects. The
degree of such effects is numerically expressed
as the toxicity equivalency factor (TEF) and is
standardized to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD; TEF = 1) (Van den Berg
et al. 2006). However, the TEF concept
might not fully encompass the developmental
neurotoxicity of PCBs, because AhR expres-
sion in the brain may be regional (Huang
et al. 2000; Petersen et al. 2000) and because
PCB congeners are considered to have neuro-
toxicities via both AhR-dependent and AhR-
independent mechanisms (Giesy and Kannan
1998; Tilson and Kodavanti 1997). Second,
PCBs may disrupt intracellular signaling path-
ways that are essential not only for brain func-
tion but also for brain development (reviewed
by Kodavanti 2005), which will disturb intra-
cellular calcium homeostasis (Kodavanti et al.
1993). For example, ortho-substituted non-
coplanar congeners might alter protein
kinase C translocation, cellular dopamine
uptake, and the formation of reactive oxygen
species. Such toxicity is referred to as the
neurotoxicity equivalent (reviewed by
Kodavanti 2005; Simon et al. 2007).
In addition to these signaling pathways, we
and several other groups have focused on the
possible interactions of these chemicals with
the thyroid hormone (TH) system (Bogazzi
et al. 2003; Iwasaki et al. 2002; Kitamura et al.
2005; Miyazaki et al. 2004). TH is crucial for
brain development, and TH deﬁciency during
the critical perinatal period has been reported
to cause cretinism, with severe cognitive
and/or mental disorders in the offspring
(Koibuchi and Chin 2000; Oppenheimer and
Schwartz 1997; Porterfield and Hendrich
1993). PCB/dioxin congeners are considered
to cause neurotoxicity by altering TH homeo-
stasis in the developing brain. Some researchers
have reported that exposure to PCB con-
geners results in thyroid enlargement and
reduced serum total thyroxine (T4) levels
with normal levels of triiodothyronine (T3),
an active compound of TH (Brouwer et al.
1998; Hauser et al. 1998; Porterﬁeld 2000),
during a possible critical period of TH action.
Certain PCB congeners were reported to
induce the expression of a microsomal
enzyme, uridine diphosphate glucuronosyl-
transferase, which glucuronizes T4 to facilitate
excretion (Hood et al. 2003; Liu et al. 1995).
Exposure to TCDD also results in morpho-
logic and functional alterations in the thyroid
of adult rodents (Gorski and Rozman 1987;
Henry and Gasiewicz 1987; Potter et al. 1986;
Van Birgelen et al. 1995). Such exposure
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BACKGROUND: Polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins, and poly-
chlorinated dibenzofurans adversely affect the health of humans and various animals. Such effects
might be partially exerted through the thyroid hormone (TH) system. We previously reported that
one of the hydroxylated PCB congeners suppresses TH receptor (TR)-mediated transcription by
dissociating TR from the TH response element (TRE). However, the binding site of PCB within
TR has not yet been identiﬁed.
OBJECTIVES: We aimed to identify the functional TR domain responsible for the PCB-mediated
suppression of TR action by comparing the magnitude of suppression using several representative
PCB/dioxin congeners.
MATERIALS AND METHODS: We generated chimeric receptors by combining TR and glucocorticoid
receptor (GR) and determined receptor-mediated transcription using transient transfection-based
reporter gene assays, and TR-TRE binding using electrophoretic mobility shift assays.
RESULTS: Although several PCB congeners, including the hydroxylated forms, suppressed TR-
mediated transcription to various degrees, 2,3,7,8-tetrachlorodibenzo-p-dioxin did not alter TR
action, but 2,3,4,7,8-pentachlorodibenzofuran weakly suppressed it. The magnitude of suppression
correlated with that of TR–TRE dissociation. The suppression by PCB congeners was evident from
experiments using chimeric receptors containing a TR DNA-binding domain (DBD) but not a
GR-DBD.
CONCLUSIONS: Several nondioxin-like PCB congeners and hydroxylated PCB compounds suppress
TR action by dissociating TR from TRE through interaction with TR-DBD.
KEY WORDS: dioxin, DNA-binding domain, polychlorinated biphenyl, thyroid hormone receptor,
transcription. Environ Health Perspect 116:1231–1236 (2008). doi:10.1289/ehp.11176 available
via http://dx.doi.org/ [Online 14 May 2008]induces not only an increase in the volume of
thyroid follicular cells, followed by hyperpla-
sia, but also follicular thyroid tumors in rats
(Huff et al. 1991; Sewall et al. 1995). Both
PCDD and PCDF induce T3 and T4 excre-
tion, thereby decreasing plasma T3 and T4 lev-
els (Bastomsky 1977; Kohn et al. 1996;
Nishimura et al. 2002). These results indicate
that PCBs/dioxins disrupt the TH system by
decreasing blood TH levels, which in turn
induces hypothyroidism in various organs.
Perinatal exposure to PCBs/dioxins in
laboratory animals induces a decrease in
plasma T4 levels without signiﬁcantly altering
the growth (Lein et al. 2007; Zoeller et al.
2000), and T3 levels remain within the normal
range (Porterfield 2000), indicating that the
toxicity of these chemicals does not manifest
by altering blood TH levels. On the other
hand, because the molecular structures of
PCBs/dioxins are similar to those of TH, these
chemicals are considered to act via TH recep-
tors (TRs) (McKinney 1989). Furthermore,
these compounds can be transferred across the
blood–brain barrier and accumulate in the
brain (Brouwer and van den Berg 1986;
Cheek et al. 1999; Darnerud et al. 1996;
McKinney 1989). These ﬁndings suggest that
PCBs/dioxins induce abnormal brain develop-
ment by directly acting on TR.
We therefore performed a series of experi-
ments and found that a hydroxylated (OH)
PCB compound [4-OH-2´,3,3´,4´,5´-penta-
chlorobiphenyl (pentaCB); 4-OH-PCB-106]
at a concentration of 10–10 M suppresses TR-
mediated transcription induced by TH
(Iwasaki et al. 2002). The magnitude of sup-
pression induced by 4-OH-PCB-106 was cell-
type dependent and most obvious in clonal
TE671 cells derived from human cerebellar
granule cells (Iwasaki et al. 2002), and this
suppression was due to the partial dissociation
of TR from the TH response element (TRE)
(Miyazaki et al. 2004). These results suggest
that PCBs directly act on TR, although the
TR functional domain responsible for PCB
action remains obscure.
Here, we report that the magnitude of the
suppression of TR-mediated transcription dif-
fers among a variety of congeners of PCBs/
dioxins. In addition, we identified the func-
tional domain responsible for PCB action
using chimeric receptors generated from TR
and the glucocorticoid receptor (GR).
Materials and Methods
Chemicals. We purchased T3 from Sigma
Chemical Co. (St. Louis, MO, USA), and
TCDD and PCDFs [2,3,4,7,8-pentachloro-
dibenzofuran (pentaCDF), 2,8-diCDF, and
2-monoCDF] from Cambridge Isotope
Laboratory (Andover, MA, USA); all
congeners were > 98% pure. We purchased
all PCB congeners [3,3´,4,4´-tetraCB
(PCB-77), 3,3´,4,4´,5-pentaCB (PCB-126),
2,3,4,4´,5-pentaCB (PCB-114); 2,3´,4,4´,5-
pentaCB (PCB-118); and 2,2´,4,4´,5,5´-
hexaCB (PCB-153)] and OH-PCBs
[4-OH-2´,3,3´,4´,5´-pentaCB (4-OH-
PCB-106); 4-OH-2,3,3´,4,5,5´-hexaCB
(4-OH-PCB-159); 4-OH-2,3,3´,5,5´,6-
hexaCB (4-OH-PCB-165); and 4-OH-
2,2´,3,4´,5,5´,6-heptaCB (4-OH-PCB-187)]
from AccuStandard Chemicals (New Haven,
CT, USA). All PCB congeners were > 99%
pure, and OH-PCBs were > 98% pure.
Plasmids. The expression vectors for
human TRβ1, GR, and mouse retinoid X
receptor β (RXRβ), as well as the 2× glucocor-
ticoid response element-luciferase (LUC)
reporter in pTAL-LUC (BD Biosciences
Clontech, Palo Alto, CA, USA) are described
elsewhere (Iwasaki et al. 2001). The LUC
reporter constructs, the chick lysozyme
(F2)–thymidine kinase (TK)-LUC, and the
artificial direct repeat TRE, direct repeat 4
(DR4)-TK-LUC, in the PT109 vector are also
described elsewhere (Koibuchi et al. 1999).
We subcloned restriction enzyme frag-
ments of the cDNA inserts of human TRβ1
Miyazaki et al.
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Figure 1. Effects of PCBs/dioxins on TR-mediated transcription (data represent mean ± SE of triplicates).
(A and B) Expression plasmids encoding TRβ1 (10 ng) were cotransfected with F2-TK-LUC reporter plas-
mid (100 ng) into CV-1 and TE671 cells, and cells were incubated with or without 10–7 M T3 and indicated
concentrations of TCDD (A) or pentaCDF (B). (C–F) Expression plasmids encoding TRβ1 (10 ng) were
cotransfected with F2-TK-LUC reporter plasmid (100 ng) into CV-1 cells, and cells were incubated with or
without T3 (10–7 M) and with indicated concentrations of PCB-114 (coplanar type; C), PCB-153 (D),
4-OH-PCB-165 (E), or 4-OH-PCB-106 (F). 
*p < 0.01, **p < 0.02, and #p < 0.05 by ANOVA, compared with TRβ1 (+), T3 (+), and TCDD (–) in A, PCDF (–) in B, and PCB (–)
in C–F.
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pcDNA3. To create human TRβ1 with NotI
and XhoI sites, we changed the oligo-
nucleotides used to create the NotI site from
Asp-97 to Arg, from Lys-98 to Pro, and from
Asp-99 to Pro. The oligonucleotides we used
to create the XhoI site were changed from
Thr-171 to Leu and from Asp-172 to Gly
(Thompson and Evans 1989). The creation
of the NotI site on GR changed Pro-416 to
Arg, whereas the creation of the XhoI site did
not alter the GR amino acid sequence.
We constructed chimeric receptors by
exchanging KpnI-NotI, NotI-XhoI, or XhoI-
XbaI restriction fragments of human TRβ1
and GR with NotI and XhoI sites.
Cell culture. We maintained CV-1 and
TE671 cells in Dulbecco’s modified Eagle’s
medium supplemented with 5 μg/mL peni-
cillin/streptomycin and 10% fetal bovine
serum deprived of small lipophilic hormone
at 37°C under a 5% CO2 atmosphere as pre-
viously described (Iwasaki et al. 2002).
Transient transfection-based reporter gene
assays. We plated cells in 24-well plates 2 days
before transfection by calcium phosphate
coprecipitation (Iwasaki et al. 2002). The
internal control was a cytomegalovirus–
β-galactosidase plasmid. Sixteen to 24 hr later,
the cells were incubated for 24 hr in fresh
medium containing T3 and/or PCBs/dioxins.
We then harvested the cells to measure the
LUC activities as previously described (Iwasaki
et al. 2002). We balanced total amounts of
DNA per well by adding pcDNA3 plasmids
(Invitrogen, San Diego, CA, USA). LUC activ-
ities were normalized to that of β-galactosidase
and then calculated as relative LUC  activity.
We repeated all transfection studies at least
twice in triplicate. Data represent means ± SEs
of triplicates. We analyzed the data by analysis
of variance (ANOVA) and by post hoc com-
parisons using Bonferroni’s multiple range test.
Electrophoretic mobility shift assay. The
methods for the electrophoretic mobility shift
assay (EMSA) have been previously described
(Satoh et al. 1996). Brieﬂy, we labeled double-
stranded oligonucleotides using the Klenow
fragment with [α-32P]-dCTP. We incubated
in vitro transcribed and translated human
TRβ1, mouse RXRβ, and 1 × 104 counts per
minute labeled nucleotides in binding buffer
[25 mM HEPES (pH 7.6), 5 mM MgCl2,
4 mM EDTA, 110 mM NaCl, 5 μg/μL bovine
serum albumin, 1 μg/μL of poly(deoxy-
inosinic-deoxycytidylic) acid sodium salt,
20% glycerol, and 2 mM dithiothreitol] with
or without 10–6 M T3 and/or 10–8 M PCBs/
dioxins for 30 min on ice. We added various
amounts of control reticulocyte lysate to some
samples to render a consistent total volume of
lysate. After incubation, the samples were
resolved by electrophoresis and visualized by
autoradiography.
Results
Effects of PCBs/dioxins on TR-mediated tran-
scription. We previously reported that several
PCB congeners, including OH metabolites
such as 4-OH-PCB-106 and a PCB mixture
(Aroclor 1254), suppress TR-mediated tran-
scription (Iwasaki et al. 2002; Miyazaki et al.
2004). Here, we further investigated the
effects of dioxins on TR-mediated transcrip-
tion in monkey ﬁbroblast-derived CV-1 and
human medulloblastoma-derived TE671 cells
using transient cotransfection experiments
(Figure 1). The most toxic congener, TCDD
(TEF = 1) (Van den Berg et al. 2006), in a
range of concentrations from 10–16 to 10–6 M,
did not suppress TR-mediated transcription
activated by 10–7 M T3 (Figure 1A). TR-medi-
ated transcription was weakly suppressed by
10–9 M pentaCDF (TEF = 0.3), which is rela-
tively higher than the effective dose of 4-OH-
PCB-106, in TE671 but not in CV-1 cells.
Among the PCDF congeners, 2,8-diCDF and
2-monoCDF did not affect TR-mediated tran-
scription (Figure 2).
We also examined the effects of several rep-
resentative PCB congeners, including coplanar
PCBs (Figure 1C), noncoplanar PCBs
(Figure 1D), and OH-PCBs (Figure 1E,F).
We selected these congeners on the basis of
their ortho-substitution profiles and 4-OH-
PCB metabolites, which had signiﬁcant effects
on TR (Iwasaki et al. 2002; Miyazaki et al.
Effects of PCBs/dioxins on thyroid hormone receptor
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Figure 2. Effects of PCBs/dioxins on TR-mediated transcription in the presence of T3 (10–7 M) in CV-1 and
TE671 cells. Down arrows indicate suppression > 50% at 10–8 M PCBs/dioxins; diagonal arrows indicate
mild suppression (signiﬁcant, but < 50% at 10–8 M); and right arrows represent no effect. TEF = 1 for the
most toxic congener, TCDD. Congeners without TEF are indicated as ND (Van den Berg et al. 2006).
TCDD 1
2,3,4,7,8-PentaCDF 0.3
2,8-DiCDF ND
2-MonoCDF ND
PCB-77 0.0001
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4-OH-PCB-187 ND
4-OH-2,2´,3,4´,5,5´,6-HeptaCB
Compound Structure TEF CV-1 TE671
Cl O
O Cl
Cl
Cl
Cl
O Cl
Cl
Cl
Cl
Cl
O
Cl
Cl
O
Cl Cl
Cl Cl
Cl
Cl Cl
Cl Cl
Cl
Cl Cl
Cl Cl
Cl
Cl
Cl Cl
Cl
Cl
Cl Cl
Cl Cl
Cl
Cl Cl
HO Cl
Cl
Cl
Cl Cl
HO Cl
Cl
Cl
Cl
Cl Cl
HO
Cl
Cl
Cl Cl
Cl Cl
HO Cl
Cl
Cl
Cl Cl
Cl2004). Both PCB-77 (non-ortho; Figure 2), a
coplanar PCB congener, and PCB-153
(di-ortho; Figure 1D), a noncoplanar PCB,
slightly suppressed TR-mediated transcrip-
tion at 10–10 M and 10–11 M, respectively,
whereas PCB-114 (mono-ortho; Figure 1C)
and 4-OH-PCB-165 (Figure 1E) had no
effects. On the other hand, 4-OH-PCB-106
(Figure 1F) effectively suppressed TR-medi-
ated transcription. Figure 2 summarizes the
results of the effects of PCB/dioxin congeners
on TR, including those from our previous
studies under the same experimental condi-
tions using CV-1 and TE671 cell lines
(Iwasaki et al. 2002; Miyazaki et al. 2004),
with a distinct difference among these com-
pounds. Hydroxylation, degree of chlorina-
tion, and structural coplanarity do not
correlate with the magnitude of suppression
of TR-mediated transcription.
Correlation of suppression of TR action
and TR-TRE dissociation. We previously
reported that suppression of TR-mediated
transcription by 4-OH-PCB-106 is induced
by partial dissociation of TR from TRE
(Miyazaki et al. 2004). We examined the
effects of PCBs/dioxins on TR-TRE binding
using EMSA. Some of the PCB/dioxin con-
geners neither altered TR-mediated transcrip-
tion nor affected TR-TRE binding. On the
other hand, the PCB congeners that sup-
pressed TR-mediated transcription effectively
dissociated TR-TRE binding, as shown as a
representative data in Figure 3. These results
suggest that the magnitude of suppression of
TR-mediated transcription by PCBs/dioxins
correlates with those of the dissociation of
TR-TRE binding, and that the site of action
of PCBs in TR may be located within the
DNA-binding domain (DBD).
PCBs alter TR-mediated transcription
through the DBD. Because several PCB con-
geners and their OH metabolites affect
TR-mediated transcription by partially dissoci-
ating TR from TRE, we determined which
functional domain of TR is affected by using
4-OH-PCB-106, which had the most suppres-
sive effect among the PCB congeners and their
OH metabolites. We previously showed that
4-OH-PCB-106 did not affect GR-mediated
transcription (Iwasaki et al. 2002). We there-
fore constructed a series of chimeric receptors
containing TR and GR functional domains
(Figure 4A). Transcription of chimeric recep-
tors containing TR-DBD was suppressed by
4-OH-PCB-106 (Figure 4B,C), whereas
4-OH-PCB-106 was not signiﬁcantly suppres-
sive when the chimeric receptors contained
GR-DBD (Figure 4B,C). These results indicate
that PCB congeners act on the TR through
DBD rather than on the TR N-terminus or
TR-ligand binding domain (LBD).
Miyazaki et al.
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Figure 3. Magnitude of TR dissociation from TRE cor-
related with that of suppression by PCBs/dioxins. NS,
nonspecific. (A) In vitro translated TRβ1 (1.5 µL)
and/or RXRβ (3 µL) incubated with [32P]-labeled
F2-TRE with or without 10–6 M T3 and 10–8 M 4-OH-
PCB-106 (4OH-P106), 4-OH-PCB-165 (4OH-P165), or
3-methyl coranthrene (3MC). The results were simi-
lar in three independent repeats of the same
experiment, and in experiments using DR4-TRE.
(B) Histogram of relative intensity of dissociated
TRβ1 from TRE by adding PCBs and 3MC. The inten-
sity values of bands are ratios of intensity values
with T3 without PCB/3MC. Results are mean ± SE of
three independent experiments.
*p < 0.01 by ANOVA and post hoc comparison using
Bonferroni’s multiple range test compared with TR/RXR (+),
T3 (+), and PCB (–). 
TR/RXR –/– –/– +/+ +/+ +/+ +/+
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Figure 4. TR-mediated transcription altered by 4-OH-PCB-106 through TR-DBD. (A) Schematic structures
and chimeric proteins used in the present study. Abbreviations: G, glucocorticoid receptor; N, N-terminal
domain; NR, nuclear hormone receptor; T, thyroid hormone receptor. (B) Representative examples of PCB
actions on chimeric receptor-induced transcription. Chimeric receptors (10 ng) were cotransfected with
F2-TK-LUC or GRE-LUC reporter plasmid (100 ng) into CV-1 cells and incubated with or without T3 (10–7 M)
or dexamethasone (DEX; 10–7 M) and 10–11–10–7 M 4-OH-PCB-106. (C) Effect of PCB on transcription
through chimeric receptors containing TR-DBD or GR-DBD. Chimeric receptors (10 ng) were cotrans-
fected with F2-TRE-LUC or GRE-LUC reporter plasmid (100 ng) into CV-1 cells and incubated with or with-
out T3 (10–7 M) or DEX (10–7 M) and 10–11–10–7 M 4-OH-PCB-106. For B and C, data represent mean ± SE of
triplicates.
*p < 0.01, and #p < 0.05 by ANOVA; for B, compared with GTG (+), DEX (+), and PCB (–).
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TGTDiscussion
In the present study, we examined how
PCBs/dioxins affect TR-mediated transcrip-
tion and found distinct effects of several PCB
congeners on TR. For example, several PCB
congeners exerted significant suppression,
whereas TCDD, the most toxic congener, did
not. The magnitude of suppression was corre-
lated with that of TR dissociation from TRE.
Furthermore, we showed that these chemicals
might act on TR-DBD.
We previously reported that the transcrip-
tion mediated by TR is suppressed by 4-OH-
PCB-106 (Iwasaki et al. 2002), and others
have shown that dioxins and coplanar PCBs
may disrupt the TH system (Bastomsky 1977;
Gorski and Rozman 1987; Henry and
Gasiewicz 1987; Kohn et al. 1996; Nishimura
et al. 2002; Potter et al. 1986; Van Birgelen
et al. 1995). Thus, we initially postulated that
dioxins, coplanar PCBs, and OH-PCB com-
pound suppress TR-mediated transcription.
Although TCDD did not exert any effects, one
PCDF congener and several PCB congeners,
including mono-ortho–substituted congeners,
suppressed TR action. On the other hand,
4-OH-PCB-165 had no suppressive effects.
These results indicate that 4-hydroxylation and
coplanarity are not essential for inducing the
suppression.
We investigated which functional domain
of TR is responsible for PCB action in a system
using a series of chimeric receptors (Figure 4)
and found that PCBs act on TR-DBD, but
not on LBD. Although PCBs do not have high
afﬁnity for TR-LBD (Cheek et al. 1999), there
are several possibilities for the interaction of
PCBs and TR-DBD. It is conceivable that
PCBs bind to and change the conformation of
TR-DBD because we found that PCBs dissoci-
ate TR-coactivator complexes from TRE but
not from TR-corepressor complexes (Miyazaki
et al. 2004) and alter the binding between
coactivators or corepressors and TR (Miyazaki
et al. 2004). Coactivators bind to the activa-
tion function-2 domain of TR, which is
located at the C-terminus of the LBD. In con-
trast, corepressors bind to a broad region of
TRs, including the hinge region that is located
immediately adjacent to the DBD. These
observations are consistent with the notion
that PCBs bind to the DBD and subsequently
change the conformation of the domain and
its surrounding region to induce the dissocia-
tion from TRE. Other possible interactions of
PCBs and TR-DBD would be masking of the
PCB-binding region of TR by corepressors
and/or alteration of the TR-DBD conforma-
tion by PCBs binding or recruitment of a
“PCB-responsive TR-binding protein.”
Although the present study revealed that
PCBs suppress TR action, Gauger et al.
(2007) found that some PCB congeners, such
as PCB-105 and/or PCB-118 (mono-ortho
PCB), may exert agonistic action toward
TR-mediated transcription in rat somatomam-
motroph-derived GH3 cells. Their study sug-
gested that OH-PCB-105 or OH-PCB-118
may be responsible for this agonistic action
toward TR because this action occurred when
cytochrome P450 (CYP) expression was
induced by PCB-126. Thus, a mixture of
coplanar and noncoplanar PCBs might result
in an agonistic effect on TR-mediated tran-
scription. On the other hand, we conﬁrmed by
semiquantitative reverse transcriptase-poly-
merase chain reaction that CYP1A1 is not
expressed in CV-1 cells and that various PCB
congeners do not induce CYP1A1 expression
[Supplemental Material, Figure 1S (available
online at http://www.ehponline.org/members/
2008/11176/suppl.pdf)]. Thus, we could
refute the possible involvement of CYP1A1
and AhR in our experimental system, and the
PCB congeners each might directly act on TR.
Dioxins/PCBs cause learning and mem-
ory impairment in children (Koopman-
Esseboom et al. 1994) and in laboratory
animals (Hojo et al. 2008; Schantz et al.
1996; Seo et al. 1999, 2000). However, the
molecular mechanisms of PCB action in the
brain have not been clarified. Because the
amounts of AhR expressed in the brain are lim-
ited, AhR’s involvement in PCB/dioxin actions
in the brain might be less than that in other
organs where it is abundant, such as the liver
and reproductive organs. Thus, other signaling
pathways may be involved in the neurotoxic
manifestations. A possible mechanism is the
disruption of intracellular signaling pathways
that depend on Ca2+ homeostasis (Kodavanti
2005; Simon et al. 2007). We have also shown
that PCB congeners alter the intracellular Ca2+
levels in cultured neurons (Okada et al. 2005),
which may be relevant to the altered expres-
sion of Ca2+ sensitive genes, such as c-Jun
(Shimokawa et al. 2006). Another possible
mechanism of neurotoxicity may be relevant
to a decreasing trend in total T4 levels in peo-
ple living in the general environment
(Koopman-Esseboom et al. 1994; Nagayama
et al. 1998). In utero and lactational exposures
to TCDD have been reported to induce thy-
roid gland hyperplasia (Nishimura et al. 2003)
or to induce the liver uridine diphosphate
glucuronosyltransferase 1 family that catalyzes
TH (Nishimura et al. 2005), which could
induce hypothyroidism. However, the magni-
tude of decrease in brain TH levels might not
be sufﬁcient to induce hypothyroidism in the
brain (Meerts et al. 2002). Instead, PCBs
might suppress TR action in the brain by dis-
sociating TR from TRE as shown in the pre-
sent study, or act as agonists of TR in cells
that express AhR and CYP1A1, as noted
above (Gauger et al. 2007). Thus, we consider
multiple pathways of PCB action to be
involved in the induction of learning and
memory disorders. Further analysis is required
to clarify the distinct role of each of these pos-
sible signaling pathways.
In summary, we examined the effects of
several representative PCB/dioxin congeners
on TR-mediated transcription. We also gen-
erated chimeric receptors from TR and GR to
identify the functional domain responsible for
PCB action. Under our experimental condi-
tions, PCBs apparently acted on the DBD of
TR. We propose that several pathways should
be considered to determine how PCB and its
related compounds exert their toxic effects.
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